Preclinical Pharmacokinetic and Pharmacological Profiling of B339, a Novel SARM1 Inhibitor for the Treatment of Vincristine-induced Peripheral Neuropathy.
- DOI
- 10.1007/s11095-026-04198-x
- Published
- 2026 Sep 15
- Container
- Pharmaceutical research
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s11095-026-04198-x,
title = {Preclinical Pharmacokinetic and Pharmacological Profiling of B339, a Novel SARM1 Inhibitor for the Treatment of Vincristine-induced Peripheral Neuropathy.},
author = {Karnik A and Hosmani GS and Dolma S and Gangopadhyay A and Lalwani A and Boga RB and Sriram D and Ravi PR and Joshi AR},
year = {2026},
journal = {Pharmaceutical research},
doi = {10.1007/s11095-026-04198-x},
url = {https://doi.org/10.1007/s11095-026-04198-x}
}RIS
TY - JOUR TI - Preclinical Pharmacokinetic and Pharmacological Profiling of B339, a Novel SARM1 Inhibitor for the Treatment of Vincristine-induced Peripheral Neuropathy. AU - Karnik A AU - Hosmani GS AU - Dolma S AU - Gangopadhyay A AU - Lalwani A AU - Boga RB AU - Sriram D AU - Ravi PR AU - Joshi AR PY - 2026 JO - Pharmaceutical research DO - 10.1007/s11095-026-04198-x UR - https://doi.org/10.1007/s11095-026-04198-x ER -
APA
A, K., GS, H., S, D., A, G., A, L., RB, B., D, S., PR, R., & AR, J. (2026). Preclinical Pharmacokinetic and Pharmacological Profiling of B339, a Novel SARM1 Inhibitor for the Treatment of Vincristine-induced Peripheral Neuropathy.. Pharmaceutical research. https://doi.org/10.1007/s11095-026-04198-x
Source records
- pubmed · retrieved 2026-09-25T20:23:35.900Z
- europe-pmc · retrieved 2026-09-25T20:23:35.910Z